In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Assets | | | | | | | | |
Loans receivable | 69.3 | 68.4 | 65.7 | | | | | |
Interest receivable on loans | 1.1 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 |
Cash | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 |
Other assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Operating lease right-of-use asset, net | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.1 |
Deferred financing costs, net | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Total assets | 70.9 | 70.0 | 67.2 | 55.1 | 55.0 | 60.1 | 59.8 | 59.0 |
|
Liabilities and Stockholders’ Equity | | | | | | | | |
Liabilities: | | | | | | | | |
Line of credit | 19.3 | 18.4 | 15.6 | 3.5 | 15.4 | 20.4 | 20.3 | 19.8 |
Senior secured notes | 5.7 | 5.7 | 5.7 | 5.7 | 5.6 | 5.6 | 5.6 | 5.6 |
Deferred origination fees | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 |
Accounts payable and accrued expenses | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
Operating lease liability | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.1 |
Dividends payable | 1.4 | 1.4 | 1.4 | | | | 1.1 | |
Total liabilities | 27.6 | 26.7 | 23.8 | 10.0 | 21.9 | 27.0 | 27.9 | 26.0 |
|
Commitments and contingencies | | | | | | | | |
Stockholders’ equity: | | | | | | | | |
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued | | | | | | | | |
Common shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Additional paid-in capital | 45.5 | 45.5 | 45.5 | 45.5 | 33.2 | 33.2 | 33.2 | 33.2 |
Treasury stock, at cost – 262,113 shares | -0.8 | -0.8 | -0.8 | -0.8 | -0.8 | -0.8 | -0.8 | -0.8 |
Accumulated deficit | -1.4 | -1.4 | -1.3 | 0.4 | 0.7 | 0.7 | -0.4 | 0.7 |
Total stockholders’ equity | 43.3 | 43.4 | 43.4 | 45.1 | 33.1 | 33.1 | 32.0 | 33.0 |
Total liabilities and stockholders’ equity | 70.9 | 70.0 | 67.2 | 55.1 | 55.0 | 60.1 | 59.8 | 59.0 |